Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 60K | Apr 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Apr 4, 2024 | 1 | $0 | 4 | Apr 8, 2024 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 1 | $150K | 4 | Jul 6, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |